- Home
- LIN vs NVS Comparison
LIN vs NVS Comparison
Compare LIN & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIN
- NVS
- Stock Information
- Founded
- LIN 1879
- NVS 1895
- Country
- LIN United Kingdom
- NVS Switzerland
- Employees
- LIN N/A
- NVS N/A
- Industry
- LIN Major Chemicals
- NVS Biotechnology: Pharmaceutical Preparations
- Sector
- LIN Industrials
- NVS Health Care
- Exchange
- LIN Nasdaq
- NVS Nasdaq
- Market Cap
- LIN 226.2B
- NVS 230.5B
- IPO Year
- LIN N/A
- NVS 1991
- Fundamental
- Price
- LIN $448.57
- NVS $103.05
- Analyst Decision
- LIN Buy
- NVS Hold
- Analyst Count
- LIN 12
- NVS 5
- Target Price
- LIN $491.90
- NVS $121.25
- AVG Volume (30 Days)
- LIN 1.9M
- NVS 1.4M
- Earning Date
- LIN 10-31-2024
- NVS 10-29-2024
- Dividend Yield
- LIN 1.24%
- NVS 3.66%
- EPS Growth
- LIN 8.95
- NVS 130.53
- EPS
- LIN 13.18
- NVS 8.58
- Revenue
- LIN $33,025,000,000.00
- NVS $49,940,000,000.00
- Revenue This Year
- LIN $2.23
- NVS $10.04
- Revenue Next Year
- LIN $5.26
- NVS $4.55
- P/E Ratio
- LIN $34.04
- NVS $11.70
- Revenue Growth
- LIN 1.77
- NVS 8.92
- 52 Week Low
- LIN $396.07
- NVS $92.35
- 52 Week High
- LIN $487.49
- NVS $120.92
- Technical
- Relative Strength Index (RSI)
- LIN 31.94
- NVS 23.61
- Support Level
- LIN $450.86
- NVS $107.94
- Resistance Level
- LIN $457.87
- NVS $104.68
- Average True Range (ATR)
- LIN 5.81
- NVS 0.94
- MACD
- LIN -1.54
- NVS -0.53
- Stochastic Oscillator
- LIN 10.85
- NVS 6.51
About LIN Linde plc
Linde PLC is the industrial gas supplier in the world, with operations in over 100 countries. The firm's main products are atmospheric gases (including oxygen, nitrogen, and argon) and process gases (including hydrogen, carbon dioxide, and helium), as well as equipment used in industrial gas production. Linde serves a wide variety of end markets, including chemicals, manufacturing, healthcare, and steelmaking. Linde generated approximately $33 billion in revenue in 2023.
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.